BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36871123)

  • 1. Standard of care drugs do not modulate activity of senescent primary human lung fibroblasts.
    Badaro-Garcia S; Hohmann MS; Coelho AL; Verri WA; Hogaboam CM
    Sci Rep; 2023 Mar; 13(1):3654. PubMed ID: 36871123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.
    Hohmann MS; Habiel DM; Coelho AL; Verri WA; Hogaboam CM
    Am J Respir Cell Mol Biol; 2019 Jan; 60(1):28-40. PubMed ID: 30109946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib.
    Zhang Y; Jones KD; Achtar-Zadeh N; Green G; Kukreja J; Xu B; Wolters PJ
    Histopathology; 2019 Jan; 74(2):341-349. PubMed ID: 30152895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human senescent fibroblasts trigger progressive lung fibrosis in mice.
    Hernandez-Gonzalez F; Prats N; Ramponi V; López-Domínguez JA; Meyer K; Aguilera M; Muñoz Martín MI; Martínez D; Agusti A; Faner R; Sellarés J; Pietrocola F; Serrano M
    Aging (Albany NY); 2023 Jul; 15(14):6641-6657. PubMed ID: 37393107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly.
    Knüppel L; Ishikawa Y; Aichler M; Heinzelmann K; Hatz R; Behr J; Walch A; Bächinger HP; Eickelberg O; Staab-Weijnitz CA
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):77-90. PubMed ID: 28257580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis.
    Wiley CD; Brumwell AN; Davis SS; Jackson JR; Valdovinos A; Calhoun C; Alimirah F; Castellanos CA; Ruan R; Wei Y; Chapman HA; Ramanathan A; Campisi J; Jourdan Le Saux C
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31687975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis.
    Finnerty JP; Ponnuswamy A; Dutta P; Abdelaziz A; Kamil H
    BMC Pulm Med; 2021 Dec; 21(1):411. PubMed ID: 34895203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nintedanib induces senolytic effect via STAT3 inhibition.
    Cho HJ; Hwang JA; Yang EJ; Kim EC; Kim JR; Kim SY; Kim YZ; Park SC; Lee YS
    Cell Death Dis; 2022 Sep; 13(9):760. PubMed ID: 36055997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.
    Bondue B; Castiaux A; Van Simaeys G; Mathey C; Sherer F; Egrise D; Lacroix S; Huaux F; Doumont G; Goldman S
    Respir Res; 2019 Jan; 20(1):10. PubMed ID: 30646908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
    Overed-Sayer C; Miranda E; Dunmore R; Liarte Marin E; Beloki L; Rassl D; Parfrey H; Carruthers A; Chahboub A; Koch S; Güler-Gane G; Kuziora M; Lewis A; Murray L; May R; Clarke D
    Thorax; 2020 Sep; 75(9):754-763. PubMed ID: 32709610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis.
    Han D; Gong H; Wei Y; Xu Y; Zhou X; Wang Z; Feng F
    Phytomedicine; 2023 Apr; 112():154680. PubMed ID: 36736168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis.
    Habiel DM; Hohmann MS; Espindola MS; Coelho AL; Jones I; Jones H; Carnibella R; Pinar I; Werdiger F; Hogaboam CM
    BMC Pulm Med; 2019 Aug; 19(1):165. PubMed ID: 31464599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts.
    Schuliga M; Pechkovsky DV; Read J; Waters DW; Blokland KEC; Reid AT; Hogaboam CM; Khalil N; Burgess JK; Prêle CM; Mutsaers SE; Jaffar J; Westall G; Grainge C; Knight DA
    J Cell Mol Med; 2018 Dec; 22(12):5847-5861. PubMed ID: 30255990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor paracrine upregulation in idiopathic pulmonary fibrosis fibroblasts is blocked by nintedanib.
    Epstein Shochet G; Brook E; Eyal O; Edelstein E; Shitrit D
    Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1025-L1034. PubMed ID: 30810067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis.
    Ebrahimpour A; Ahir M; Wang M; Jegga AG; Bonnen MD; Eissa NT; Montesi SB; Raghu G; Ghebre YT
    Sci Rep; 2022 Nov; 12(1):20668. PubMed ID: 36450789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
    Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
    Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
    Im J; Kim K; Hergert P; Nho RS
    J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell senescence and fibrotic lung diseases.
    Liu RM; Liu G
    Exp Gerontol; 2020 Apr; 132():110836. PubMed ID: 31958492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.